Second-generation 1,2,4-benzotriazine 1,4-di-N-oxide bioreductive anti-tumor agents : pharmacology and activity in vitro and in vivoMINCHINTON, A. I; LEMMON, M. J; TRACY, M et al.International journal of radiation oncology, biology, physics. 1992, Vol 22, Num 4, pp 701-705, issn 0360-3016Conference Paper

Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiationBROWN, J. M; PHIL, D; LEMMON, M. J et al.International journal of radiation oncology, biology, physics. 1991, Vol 20, Num 3, pp 457-461, issn 0360-3016Article

Aerobic radiosensitization by SR 4233 in vitro and in vivoZEMAN, E. M; LEMMON, M. J; BROWN, J. M et al.International journal of radiation oncology, biology, physics. 1990, Vol 18, Num 1, pp 125-132, issn 0360-3016Article

The influence of irradiation of the tumor bed on tumor hypoxia : measurements by radiation response, oxygen electrodes, and nitroimidazole bindingIL HAN KIM; LEMMON, M. J; BROWN, J. M et al.Radiation research. 1993, Vol 135, Num 3, pp 411-417, issn 0033-7587Article

Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamideBROWN, J. M; LEMMON, M. J; HORSMAN, M. R et al.International journal of radiation biology (Print). 1991, Vol 59, Num 3, pp 739-748, issn 0955-3002, 10 p.Article

Hydrazaline does not increase hypoxia in tumors growing in preirradiated tissueLEMMON, M. J; BROWN, J. M.International journal of radiation oncology, biology, physics. 1991, Vol 21, Num 6, pp 1435-1440, issn 0360-3016Article

Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumorsBROWN, J. M; LEMMON, M. J.Cancer research (Baltimore). 1990, Vol 50, Num 24, pp 7745-7749, issn 0008-5472, 5 p.Article

Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironmentLEMMON, M. J; VAN ZIJL, P; FOX, M. E et al.Gene therapy (Basingstoke). 1997, Vol 4, Num 8, pp 791-796, issn 0969-7128Article

Anaerobic bacteria as a delivery system for cancer gene therapy : in vitro activation of 5-fluorocytosine by genetically engineered clostridiaFOX, M. E; LEMMON, M. J; MAUCHLINE, M. L et al.Gene therapy (Basingstoke). 1996, Vol 3, Num 2, pp 173-178, issn 0969-7128Article

Chemotherapeutic tumour targeting using clostridial sporesMINTON, N. P; MAUCHLINE, M. L; LEMMON, M. J et al.FEMS microbiology reviews. 1995, Vol 17, Num 3, pp 357-364, issn 0168-6445Conference Paper